INDIANAPOLIS, Nov. 8, 2010 /PRNewswire/ — Roche (SIX: RO, ROG;
OTCQX: RHHBY) and Voluntis S.A. announced today the introduction of
CoaguChek(R) Link, a versatile online resource that helps simplify
and streamline the process of managing patients on anticoagulation
therapy.
The web-based application gives patients who self-test their
PT/INR (clotting time) a simple, convenient way to report their
test results and gives doctors a single, secure site to access data
to more effectively monitor and manage their patients on warfarin
therapy. It is available to physicians who prescribe a patient
self-testing program through CoaguChek Patient Services (CPS), an
Independent Diagnostic Testing Facility that provides support
services for physicians and their patients. The application is
based on the Medpassport platform developed by Voluntis, a
healthcare software company specializing in Patient Relationship
Management.
“CoaguChek Link helps doctors and their patients stay connected
so they can work together to manage the patient’s anticoagulation
therapy more effectively, whether the patient is at home or away,”
said Tim Huston, director of marketing, professional diagnostics at
Roche Diagnostics Corporation. “It simplifies the process for
everyone, facilitates better therapy management, and contributes to
the goal of helping improve patient outcomes.”
CoaguChek Link offers healthcare providers a convenient patient
management resource, helping to simplify documentation and
streamline office workflow so they can focus on patients that
require follow-up care. Clinics and physician offices can use the
application (coagucheklink.com) to quickly enroll patients with
CPS, educate them about their therapy, view test results in real
time through a password-protected portal, modify recommended test
frequency or acceptable ranges for patient test results, and
generally access the information needed to monitor and adjust a
patient’s anticoagulant therapy from an
‘/>”/>
